All lobbying filings

The McManus Group

The McManus Group filed a Q2 report for Biowound Solutions on August 4, 2025, reporting $50,000 in lobbying income.

Lobbying for Biowound Solutions · Biologics Company

As filed: THE MCMANUS GROUP for BIOWOUND SOLUTIONS.

All filings by The McManus Group · Everything Biowound Solutions has reported

Filing · LD-2 quarterly report Q2 report

Reporting period

2nd Quarter 2025

Apr 1 - June 30 · Posted Aug 4, 2025

Income

$50,000

What the client paid this registrant for the period.

Client based in

Nevada

Official filing document

Government bodies contacted 5

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Medicare/Medicaid

Issues related to coverage of and reimbursement for Human Cell & Tissue products, including Local Coverage Determination L39764- Skin Substitute Grafts/Cellular and Tissue-Based Products for the Treatment of Diabetic Foot Ulcers and Venous Leg Ulcers.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.